AU-224 |
| Katalog-Nr.GC31568 |
AU-224 ist ein Benzamid-Derivat, das als vielversprechendes gastrointestinales Prokinetikum ohne signifikante Nebenwirkungen verwendet wird.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 287399-47-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
AU-224 is a benzamide derivative used as a promising gastrointestinal prokinetic agent without significant side effects.
AU-224 is a benzamide derivative used as a promising gastrointestinal prokinetic agent without significant side effects.
AU-224 has excellent effect of promoting digestive motion while showing little side effect and can be orally administered[1]. AU-224 shows only weak gastrointestinal prokinetic activity after oral administration due to its low lipophilicity[2].
[1]. WO/2000/046201A1 [2]. Sakaguchi J, et al. An improved synthesis of butyl 4-[(4-amino-5-chloro-2-methoxybenzoyl)amino]-1-piperidineacetate (AU-224). Chem Pharm Bull (Tokyo). 2001 Jun;49(6):788-90.
Average Rating: 5 (Based on Reviews and 37 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *